Tag: Magellan RX

ALEXANDRIA, Va. – The Federal Trade Commission should sue to block Prime Therapeutics LLC/Express Scripts from acquiring Magellan RX Management, says the National Community Pharmacists Association in a letter to Holly Vedova, director to the FTC’s Bureau of Competition. If the merger were to proceed, it would allow Express Scripts/Prime to steer patients even more easily to its own mail-order pharmacies for specialty drugs and potentially supply it with valuable insight into claims-level...